Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection

Rationale: Fosfomycin/tobramycin for inhalation (FTI), a unique, broad-spectrum antibiotic combination, may have therapeutic potential for patients with cystic fibrosis (CF). Objectives: To evaluate safety and efficacy of FTI (160/40 mg or 80/20 mg), administered twice daily for 28 days versus place...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Trapnell, Bruce C., McColley, Susanna A., Kissner, Dana G., Rolfe, Mark W., Rosen, Jonathan M., McKevitt, Matthew, Moorehead, Lisa, Montgomery, A. Bruce, Geller, David E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3361752/
https://ncbi.nlm.nih.gov/pubmed/22095545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201105-0924OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados